Based on the bioinformatics analyses and experimental verification presented in this study, we concluded from these results that anti-POSTN and anti-TIMP1 autoantibodies could be considered potential diagnostic markers for ESCC. This evidence concerns the gene TIMP1 and esophageal squamous cell carcinoma.